Houston, Texas, United States
Dr. Morris is a former CEO and tech-savvy Independent Director for both public and private companies. Dr. Morris has over 30 years of operating experience within Fortune 500, Mid-, Small- and Micro-Cap companies and is nationally recognized (AIMBE) for his leadership in successful commercialization of high-tech medical devices. Dr. Morris has a passion for, and a successful track record of leading turnarounds, building high performing teams, and leveraging positive product differentiation in highly regulated global markets to grow value.
Audit Committee Governance & Sustainability Committee
Compensation Committee Technology, Quality & Regulatory Committee
Compensation Committee Chair, Technology Committee
At MEHL BioMedical, LLC our mission is to help companies extend and improve the lives of patients struggling with debilitating health conditions.
As its former Chairman and CEO, Dr. Morris led the restart of Neuspera Medical Corporation (legacy Vivonda) — successfully raising $120m of capital across 4 financings and growing its value over 400x. During his 7 year tenure, Neuspera achieved FDA approval to commercialize its novel ultraminiaturized neuromodulation system for use in Peripheral Pain and an FDA approval to complete its pivotal trial for Urge Urinary Incontinence -- a second large market vertical effecting ~7% of the adult population.